By Michael Nevradakis, Ph.D. Japan is offering a self-amplifying mRNA vaccine as one of the five routine COVID-19 vaccines available to the public for the 2024-2025 fall and…
Posts tagged as “mRNA platform”
Moderna halted its Phase 1 trial of an mRNA vaccine to treat the Epstein-Barr virus after a single suspected case of myocarditis in an adolescent,…